
© 2025 ARIVA.de
Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
09:17 | BofAS Lifts CSPC PHARMA TP to HKD5.1, Maintains Underperform Rating | ||
Fr | CSPC PHARMA (01093): VOLUNTARY ANNOUNCEMENT - SYH2068 INJECTION (A DOUBLE-STRANDED SMALL INTERFERING RNA DRUG) OBTAINS CLINICAL TRIAL APPROVAL | ||
Mi | CSPC PHARMA (01093): UNAUDITED FINANCIAL INFORMATION OF CSPC INNOVATION PHARMACEUTICAL CO., LTD. FOR THE THREE MONTHS ENDED 31 MARCH 2025 | ||
Di | CSPC PHARMA (01093): VOLUNTARY ANNOUNCEMENT - PRUSOGLIPTIN AND METFORMIN EXTENDED-RELEASE TABLETS OBTAINS CLINICAL TRIAL APPROVAL | ||
Di | CSPC PHARMA (01093): VOLUNTARY ANNOUNCEMENT - JMT203 (ANTI-GFRAL MONOCLONAL ANTIBODY) OBTAINS CLINICAL TRIAL APPROVAL IN THE U.S. |